Skip to main content
SpringerLink
Log in

Nobiletin acts anti-inflammatory on murine IL-10−/− colitis and human intestinal fibroblasts

  • Original Contribution
  • Published:
European Journal of Nutrition Aims and scope Submit manuscript

Abstract

Purpose

Inflammatory bowel disease (IBD) shows increasing prevalence over the last years. We propose that anti-inflammatory plant substances could be used as additional or alternative agents with good compliance in prevention and/or therapy of IBD and its complication intestinal fibrosis. We could recently show that the citrus flavonoid nobiletin acts anti-inflammatory on activation of intestinal mast cells. Here, we analysed the effects of nobiletin on inflammation and fibrosis in IL-10−/− colitis.

Methods

IL-10−/− and wild-type (WT) mice were orally treated with/without vehicle or nobiletin. Clinical symptoms of colitis and disease activity index (DAI) were assessed, and colon tissue was analysed for tissue damage, cellular infiltration, bowel wall thickness, mast cell number and degranulation, as well as collagen deposition as marker for fibrosis. Human intestinal fibroblasts (hiFB) were treated with nobiletin and the expression of collagen and pro-inflammatory cytokines was measured.

Results

Nobiletin treatment of IL-10−/− mice resulted in a reduction of clinical colitis symptoms and a longer survival time. In addition, histological scores of colitis were reduced compared to control groups. Mast cell number and degranulation was lower in nobiletin treated IL-10−/− mice, and correlated positively with DAI. As well, fibrotic marker of collagen deposition was reduced by nobiletin. In hiFB, the expression of collagen as well as of pro-inflammatory cytokines IL-6, TNF and CCL2 was down-regulated by nobiletin treatment.

Conclusions

Nobiletin decreases inflammatory symptoms and markers in murine colitis as well as fibrotic collagen deposition and expression. Thus, nobiletin could be a potential new agent in therapy of chronic colitis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. M’Koma AE (2013) Inflammatory bowel disease: an expanding global health problem. Clin Med Insights Gastroenterol 6:33–47

    PubMed  PubMed Central  Google Scholar 

  2. Preiß J, Bokemeyer B, Buhr H, Dignaß A, Häuser W, Hartmann F et al (2014) Aktualisierte S3-Leitlinie—“Diagnostik und Therapie updated german clinical practice guideline on” Diagnosis and treatment of Crohn’s disease” 2014. Z Gastroenterol 52:1431–1484

    Article  PubMed  Google Scholar 

  3. Baumgart DC, Baumgart DC, Carding SR, Carding SR (2007) Series gastroenterology 1 Inflammatory bowel disease: cause and immunobiology. Lancet 369:1627–1640

    Article  CAS  PubMed  Google Scholar 

  4. Luchini AC, Rodrigues-Orsi P, Cestari SH, Seito LN, Witaicenis A, Pellizzon CH, Di Stasi LC (2008) Intestinal anti-inflammatory activity of coumarin and 4-hydroxycoumarin in the trinitrobenzensulphonic acid model of rat colitis. Biol Pharm Bull 31:1343–1350

    Article  CAS  PubMed  Google Scholar 

  5. Hagenlocher Y, Hösel A, Bischoff SC, Lorentz A (2016) Cinnamon extract reduces symptoms, inflammatory mediators and mast cell markers in murine IL-10–/– colitis. J Nutr Biochem 30:85–92

    Article  CAS  PubMed  Google Scholar 

  6. Azuma T, Shigeshiro M, Kodama M, Tanabe S, Suzuki T (2013) Supplemental naringenin prevents intestinal barrier defects and inflammation in colitis mice. J Nutr 143:827–834

    Article  CAS  PubMed  Google Scholar 

  7. Burke JP, Mulsow JJ, O’Keane C, Docherty NG (2007) Fibrogenesis in Crohn’s disease. Am J Gastroenterol 102:439–448

    Article  CAS  PubMed  Google Scholar 

  8. Carter MJ, Lobo AJ, Travis SP, Section IBD (2004) British Society of Gastroenterology. Guidelines for management of inflammatory bowel disease in adults. Gut 53:V1–V16

    Article  PubMed  PubMed Central  Google Scholar 

  9. Regan MC, Flavin BM, Fitzpatrick JM, O’Connell PR (2000) Stricture formation in Crohn’s Disease—the role of intestinal fibroblasts. Ann Surg 231:46–50

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Gaydou EM, Bianchini J, Randriamiharisoa RP (1987) Orange and mandarin peel oils differentiation using polymethoxylated flavone composition. J Agric Food Chem 35:525–529

    Article  CAS  Google Scholar 

  11. Dugo P, Mondello L, Dugo L, Stancanelli R, Dugo G (2000) LC-MS for the identification of oxygen heterocyclic compounds in citrus essential oils. J Pharm Biomed Anal 24:147–154

    Article  CAS  PubMed  Google Scholar 

  12. Evans M, Sharma P, Guthrie N (2004) Bioavailability of citrus polymethoxylated flavones and their biological role in metabolic syndrome and hyperlipidemia. Readings Adv Pharmacokinet—Theory, Methods Appl, pp 267–85

  13. Seki T, Kamiya T, Furukawa K, Azumi M, Ishizuka S, Takayama S et al (2013) Nobiletin-rich Citrus reticulate peels, a kampo medicine for Alzheimer’s disease: a case series. Geriatr Gerontol Int 13:236–238

    Article  PubMed  Google Scholar 

  14. Tang MX, Ogawa K, Asamoto M, Chewonarin T, Suzuki S, Tanaka T et al (2011) Effects of nobiletin on PhIP-induced prostate and colon carcinogenesis in F344 rats. Nutr Cancer 63:227–233

    Article  CAS  PubMed  Google Scholar 

  15. Wu YQ, Zhou CH, Tao J, Li SN (2006) Antagonistic effects of nobiletin, a polymethoxyflavonoid, on eosinophilic airway inflammation of asthmatic rats and relevant mechanisms. Life Sci 78:2689–2696

    Article  CAS  PubMed  Google Scholar 

  16. Guo S, Qiu P, Xu G, Wu X, Dong P, Yang G et al (2012) Synergistic anti-inflammatory effects of nobiletin and sulforaphane in lipopolysaccharide-stimulated RAW 264.7 cells. J Agric Food Chem 60:2157–2164

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Murakami A, Nakamura Y, Torikai K, Stress O, Promotion T, Tanaka T et al (2000) Inhibitory effect of citrus nobiletin on phorbol ester-induced skin inflammation, oxidative stress, and tumor promotion in mice. Cancer Res 60:5059–5066

    CAS  PubMed  Google Scholar 

  18. Wu Y, Song M, Rakariyatham K, Zheng J, Guo S, Tang Z et al (2015) Anti-inflammatory effects of 4′-demethylnobiletin, a major metabolite of nobiletin. J Funct Foods 19:278–287

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Li W, Wang X, Niu X, Zhang H, He Z, Wang Y et al (2016) Protective effects of nobiletin against endotoxic shock in mice through inhibiting TNF-α, IL-6, and HMGB1 and regulating NF-κB pathway. Inflammation 39:786–797

    Article  CAS  PubMed  Google Scholar 

  20. Hagenlocher Y, Feilhauer K, Schäffer M, Bischoff SC, Lorentz A (2017) Citrus peel polymethoxyflavones nobiletin and tangeretin suppress LPS- and IgE-mediated activation of human intestinal mast cells. Eur J Nutr 56:1609–1620

    Article  CAS  PubMed  Google Scholar 

  21. Xiong Y, Chen D, Yu C, Lv B, Peng J, Wang J et al (2015) Citrus nobiletin ameliorates experimental colitis by reducing inflammation and restoring impaired intestinal barrier function. Mol Nutr Food Res 59:829–842

    Article  CAS  PubMed  Google Scholar 

  22. Rieder F, Kessler S, Sans M, Fiocchi C (2012) Animal models of intestinal fibrosis: new tools for the understanding of pathogenesis and therapy of human disease. Am J Physiol Gastrointest Liver Physiol 303:G786–G801

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Lorentz A, Sellge G, Bischoff SC (2015) Isolation and characterization of human intestinal mast cells. Methods Mol Biol 1220:163–177

    Article  CAS  PubMed  Google Scholar 

  24. Sellge G, Lorentz A, Gebhardt T, Levi-Schaffer F et al (2004) Human intestinal fibroblasts prevent apoptosis in human intestinal mast cells by a mechanism independent of stem cell factor, IL-3, IL-4, and nerve growth factor. J Immunol 172:260–267

    Article  CAS  PubMed  Google Scholar 

  25. Lund PK, Zuniga CC (2001) Intestinal fibrosis in human and experimental inflammatory bowel disease. Curr Opin Gastroenterol 17:318–323

    Article  CAS  PubMed  Google Scholar 

  26. Jacob C, Yang PC, Darmoul D, Amadesi S, Saito T, Cottrell GS et al (2005) Mast cell tryptase controls paracellular permeability of the intestine. Role of protease activated receprot 2 and beta-arrestins. J Biol Chem 280:31936–31948

    Article  CAS  PubMed  Google Scholar 

  27. Chichlowski M, Westwood GS, Abraham SN, Hale LP (2010) Role of mast cells in inflammatory bowel disease and inflammation-associated colorectal neoplasia in IL-10 deficient mice. PLoS One 5:e12220

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Latella G, Sferra R, Speca S, Vetuschi A, Gaudio E (2013) Can we prevent, reduce or reverse intestinal fibrosis in IBD. Eur Rev Med Pharmacol Sci 17:1283–1304

    CAS  PubMed  Google Scholar 

  29. Holgersen K, Kvist PH, Markholst H, Hansen AK, Holm TL (2014) Characterisation of enterocolitis in the piroxicam-accelerated interleukin-10 knock out mouse—a model mimicking inflammatory bowel disease. J Crohn’s Colitis 8:147–160

    Article  Google Scholar 

  30. Hemler ME (1990) VLA proteins in the integrin family: structures, functions, and their role on leukocytes. Annu Rev Immunol 8:365–400

    Article  CAS  PubMed  Google Scholar 

  31. Krieglstein CF, Cerwinka WH, Sprague AG, Laroux FS, Grisham MB, Koteliansky VE et al (2002) Collagen-binding integrin alpha 1 beta 1 regulates intestinal inflammation in experimental colitis. J Clin Invest 110:1773–1782

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Nykvist P, Tu H, Ivaska J, Käpylä J, Pihlajaniemi T, Heino J (2000) Distinct recognition of collagen subtypes by α1β1 and α2β1 integrins. α1β1 mediates cell adhesion to type XIII collagen. J Biol Chem 275:8255–8261

    Article  CAS  PubMed  Google Scholar 

  33. Rieder F, Fiocchi C (2009) Intestinal fibrosis in IBD—a dynamic, multifactorial process. Nat Rev Gastroenterol Hepatol 6:28–35

    Article  CAS  Google Scholar 

  34. Dennis J, Meehan DT, Delimont D, Zallocchi M, Perry GA, O’Brien S et al (2010) Collagen XIII induced in vascular endothelium mediates α1β1 integrin-dependent transmigration of monocytes in renal fibrosis. Am J Pathol 177:2527–2540

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Choi SY, Hwang JH, Ko HC, Park JG, Kim SJ (2007) Nobiletin from citrus peel inhibits the DNA-binding activity of NF-κB and ROS production in LPS-activated RAW 264.7 cells. J Ethn Pharmacol 113:149–155

    CAS  Google Scholar 

  36. Choi SY, Ko HC, Ko SY, Hwang JH, Park JG, Kang SH, Han SH, Yun SH, Kim SJ (2007) Correlation between flavonoid content and the NO production inhibitory activity of peel extracts from various citrus fruits. Biol Pharm Bull 30:772–778

    Article  CAS  PubMed  Google Scholar 

  37. Lin N, Sato T, Takayama Y, Mimaki Y, Sashida Y, Yano M, Ito A (2003) Novel anti-inflammatory actions of nobiletin, a citrus polymethoxy flavonoid, on human synovial fibroblasts and mouse macrophages. Biochem Pharmacaol 65:2065–2071

    Article  CAS  Google Scholar 

  38. Ihara H, Yamamoto H, Ida T, Tsutsuki H, Sakamoto T, Fujita T, Okada T, Kozaki S (2012) Inhibition of nitric oxide production and inducible nitric oxide synthase expression by a polymethoxyflavone from young fruits of Citrus unshiu in rat primary astrocytes. Biosci Biotechnol Biochem 76:1843–1848

    Article  CAS  PubMed  Google Scholar 

  39. Hagenlocher Y, Bergheim I, Zacheja S, Schäffer M, Bischoff SC, Lorentz A (2013) Cinnamon extract inhibits degranulation and de novo synthesis of inflammatory mediators in mast cells. Allergy 68:490–497

    Article  CAS  PubMed  Google Scholar 

  40. Hagenlocher Y, Satzinger S, Civelek M, Feilhauer K, Köninger J, Bischoff SC, Lorentz A (2017) Cinnamon reduces inflammatory response in intestinal fibroblasts in vitro and fibrosis in vivo. Mol Nutr Food Res. https://doi.org/10.1002/mnfr.201601085 (Epub 2017 May 12)

    Article  PubMed  Google Scholar 

  41. Azuma T, Shigeshiro M, Kodama M, Tanabe S, Suzuki T (2013) Supplemental naringenin prevents intestinal barrier defects and inflammation in colitic mice 1–3. J Nutr 143:827–834

    Article  CAS  PubMed  Google Scholar 

  42. Xu L, Yang Z, Li P, Zhou Y (2009) Modulating effect of Hesperidin on experimental murine colitis induced by dextran sulfate sodium. Phytomedicine 16:989–995

    Article  CAS  PubMed  Google Scholar 

  43. Kühn R, Löhler J, Rennick D, Rajewsky K, Müller W (1993) Interleukin-10 deficient mice develop chronic enterocolitis. Cell 75:263–274

    Article  PubMed  Google Scholar 

  44. Rijnierse A, Nijkamp FP, Kraneveld AD (2007) Mast cells and nerves tickle in the tummy. Implications for inflammatory bowel disease and irritable bowel syndrome. Pharmacol Ther 116:207–235

    Article  CAS  PubMed  Google Scholar 

  45. Bischoff SC (2016) Mast cells in gastrointestinal disorders. Eur J Pharmacol 778:139–145

    Article  CAS  PubMed  Google Scholar 

  46. Menozzi A, Pozzoli C, Poli E, Lazzaretti M, Grandi D, Coruzzi G (2006) Long-term study of TNBS-induced colitis in rats: focus on mast cells. Inflamm Res 55:416–422

    Article  CAS  PubMed  Google Scholar 

  47. He SH (2004) Key role of mast cells and their major secretory products in inflammatory bowel disease. World J Gastroenterol 10:309–318

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Jacob C, Yang PC, Darmoul D, Amadesi S, Saito T, Cottrell GS et al (2005) Mast cell tryptase controls paracellular permeability of the intestine. Role of protease-activated receptor 2 and beta-arrestins. J Biol Chem 280:31936–31948

    Article  CAS  PubMed  Google Scholar 

  49. Polukort SH, Rovatti J, Carlson L, Thompson C, Ser-Dolansky J, Kinney SR, Schneider SS, Mathias CB (2016) IL-10 enhances IgE-mediated mast cell responses and is essential for the development of experimental food allergy in IL-10-deficient mice. J Immunol 196:4865–4876

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Adedara IA, Ajayi BO, Awogbindin IO, Farombi EO (2017) Interactive effects of ethanol on ulcerative colitis and its associated testicular dysfunction in pubertal BALB/c mice. Alcohol 64:65–75

    Article  CAS  PubMed  Google Scholar 

  51. Speca S, Rousseaux C, Dubuquoy C, Rieder F, Vetuschi A, Sferra R et al (2016) The novel PPARγ modulator GED-0507-34 Levo ameliorates inflammation-driven intestinal fibrosis. Inflamm Bowl Dis 22:279–292

    Article  Google Scholar 

  52. Suzuki K, Sun X, Nagata M, Kawase T, Yamaguchi H, Sukumaran V et al (2011) Analysis of intestinal fibrosis in chronic colitis in mice induced by dextran sulfate sodium. Pathol Int 61:228–238

    Article  CAS  PubMed  Google Scholar 

  53. Zhang N, Yang Z, Xiang SZ, Jin YG, Wei WY, Bian ZY et al (2016) Nobiletin attenuates cardiac dysfunction, oxidative stress, and inflammatory in streptozotocin: induced diabetic cardiomyopathy. Mol Cell Biochem 417:87–96

    Article  CAS  Google Scholar 

  54. Lim SW, Lee DR, Choi BK, Kim HS, Yang SH, Suh JW et al (2016) Protective effects of a polymethoxy flavonoids-rich Citrus aurantium peel extract on liver fibrosis induced by bile duct ligation in mice. Asian Pac J Trop Med 9:1158–1164

    Article  CAS  PubMed  Google Scholar 

  55. Lee MH, Yoon S, Moon JO (2004) The flavonoid naringenin inhibits dimethylnitrosamine-induced liver damage in rats. Biol Pharm Bull 27:72–76

    Google Scholar 

  56. Schulzke JD, Ploeger S, Amasheh M, Fromm A, Zeissig S, Troeger H et al (2009) Epithelial tight junctions in intestinal inflammation. Ann N Y Acad Sci 1165:294–300

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The authors thank Yvonne Soltow for excellent technical assistance.

Author information

Authors and Affiliations

  1. Department of Nutritional Medicine, University of Hohenheim, Fruwirthstraße 12, 70593, Stuttgart, Germany

    Yvonne Hagenlocher, Sonja Gommeringer, Anna Held, Stephan C. Bischoff & Axel Lorentz

  2. Clinic for Visceral Surgery, Katharinenhospital, Kriegsbergstraße 60, 70174, Stuttgart, Germany

    Katharina Feilhauer & Jörg Köninger

Authors
  1. Yvonne Hagenlocher
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sonja Gommeringer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Anna Held
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Katharina Feilhauer
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jörg Köninger
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Stephan C. Bischoff
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Axel Lorentz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Axel Lorentz.

Ethics declarations

Ethical standards

Surgery tissue specimen from patients undergoing bowel resection served for isolation of human fiboblasts. This study has been approved by the local ethics committee and has therefore been performed in accordance with the ethical standards.

Informed consent

All persons gave their informed consent prior to their inclusion in the study.

Conflict of interest

All authors declare no conflicts of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hagenlocher, Y., Gommeringer, S., Held, A. et al. Nobiletin acts anti-inflammatory on murine IL-10−/− colitis and human intestinal fibroblasts. Eur J Nutr 58, 1391–1401 (2019). https://doi.org/10.1007/s00394-018-1661-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00394-018-1661-x

Keywords

Search

Navigation